PON1 Antibodies

Santa Cruz Biotechnology offers a broad range of PON1 monoclonal antibodies for investigating paraoxonase 1 (PON1) in various biological processes. PON1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PON1 is an essential enzyme that hydrolyzes organophosphates and maintains crucial functions in lipid metabolism and antioxidant defense. Research has shown that PON1 activity significantly impacts cardiovascular health and aids in detoxifying harmful substances. PON1 has emerged as a key research focus in various conditions, including atherosclerosis and neurodegenerative disorders. Investigating PON1 function and regulation can reveal new therapeutic approaches for treating these conditions. Current studies highlight PON1's role in protecting against oxidative stress and inflammation. Ongoing research continues to uncover new aspects of PON1's biological significance and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of PON1's role in health and disease.